Medications

Novartis, Roche team up on COVID pneumonia drug

Novartis announced Thursday it will join forces with fellow Swiss pharmaceutical giant Roche to produce tocilizumab, a drug being tested for its effectiveness against COVID-19-linked pneumonia.

Inflammatory disorders

Self-assembling nanofibers prevent damage from inflammation

Biomedical engineers at Duke University have developed a self-assembling nanomaterial that can help limit damage caused by inflammatory diseases by activating key cells in the immune system. In mouse models of psoriasis, ...

Cardiology

CVD risk factors tied to disease activity, disability in RA

(HealthDay)—Cardiovascular disease (CVD) risk factors alone, or in combination, are associated with higher disease activity and disability in rheumatoid arthritis (RA), according to a study recently published in Therapeutic ...

Arthritis & Rheumatism

Treatment to lower RA disease activity feasible in pregnancy

(HealthDay)—Low disease activity and remission are feasible goals for women with rheumatoid arthritis (RA) cared for with a modern treatment approach during pregnancy, according to a study published online Feb. 10 in the ...

page 34 from 40